Siobhan Ennis
Burnaby, BC J1H5N4, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
A reversible broad-spectrum antiviral targets the human V-ATPase VO domain.
Journal: Research square
Published: June 12, 2026
TMPRSS2 inhibitors with broad-spectrum efficacy against SARS-CoV-2 (JN.1) and influenza A (H1N1) viruses protect mice from influenza A infection.
Journal: Emerging microbes & infections
Published: January 30, 2026
From N-0385 to N-0920: Unveiling a Host-Directed Protease Inhibitor with Picomolar Antiviral Efficacy against Prevalent SARS-CoV-2 Variants.
Journal: Journal of medicinal chemistry
Published: March 31, 2025
Nanomolar anti-SARS-CoV-2 Omicron activity of the host-directed TMPRSS2 inhibitor N-0385 and synergistic action with direct-acting antivirals.
Journal: Antiviral research
Published: February 05, 2024
A novel class of broad-spectrum active-site-directed 3C-like protease inhibitors with nanomolar antiviral activity against highly immune-evasive SARS-CoV-2 Omicron subvariants.
Journal: Emerging microbes & infections
Published: August 09, 2023
Synthetic Analogs of the Sponge Sesterterpenoid Alotaketal C are Potent Inhibitors of SARS-CoV-2 Omicron BA.1 and BA.5 Infections of Human Lung Cells.
Journal: Organic letters
Published: June 26, 2023
Corrigendum to "Discovery of lead natural products for developing pan-SARS-CoV-2 therapeutics" "Antiviral Research 209 (2023)/105484".
Journal: Antiviral research
Published: March 31, 2023
Berbamine suppresses intestinal SARS-CoV-2 infection via a BNIP3-dependent autophagy blockade.
Journal: Emerging microbes & infections
Published: March 23, 2023
SARS-CoV-2 live virus neutralization after four COVID-19 vaccine doses in people with HIV receiving suppressive antiretroviral therapy.
Journal: AIDS (London, England)
Published: February 15, 2023
Antibody response durability following three-dose coronavirus disease 2019 vaccination in people with HIV receiving suppressive antiretroviral therapy.
Journal: AIDS (London, England)
Published: December 22, 2022
Discovery of lead natural products for developing pan-SARS-CoV-2 therapeutics.
Journal: Antiviral research
Published: October 18, 2022
Impact of Age and Severe Acute Respiratory Syndrome Coronavirus 2 Breakthrough Infection on Humoral Immune Responses After Three Doses of Coronavirus Disease 2019 mRNA Vaccine.
Journal: Open forum infectious diseases
Published: October 03, 2022
Last Updated: 09/26/2026